The therapeutic effect induced by Hsp-targeting has been also validated by Hsp70- and Hsp90-based anti-cancer vaccines, which are able to contrast tumor progression by an antigen specific cell-mediated response (117). Here, HSP90B2P is linked to neoplasm.